Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer

Bibliographic Details
Main Authors: Baselga, J., Gomez, P., Greil, R., Braga, S., Climent, M., Wardley, A., Kaufman, B., Stemmer, S., Pego, A., Chan, Arlene, Goeminne, J., Graas, M., Kennedy, J., Ciruelos, E.M., Schneeweiss, A., Zubel, A., Groos, J., Melezinkova, H., Awada, A.
Format: Journal Article
Published: American Society of Clinical Oncology 2013
Online Access:http://hdl.handle.net/20.500.11937/8601
_version_ 1848745706031939584
author Baselga, J.
Gomez, P.
Greil, R.
Braga, S.
Climent, M.
Wardley, A.
Kaufman, B.
Stemmer, S.
Pego, A.
Chan, Arlene
Goeminne, J.
Graas, M.
Kennedy, J.
Ciruelos, E.M.
Schneeweiss, A.
Zubel, A.
Groos, J.
Melezinkova, H.
Awada, A.
author_facet Baselga, J.
Gomez, P.
Greil, R.
Braga, S.
Climent, M.
Wardley, A.
Kaufman, B.
Stemmer, S.
Pego, A.
Chan, Arlene
Goeminne, J.
Graas, M.
Kennedy, J.
Ciruelos, E.M.
Schneeweiss, A.
Zubel, A.
Groos, J.
Melezinkova, H.
Awada, A.
author_sort Baselga, J.
building Curtin Institutional Repository
collection Online Access
first_indexed 2025-11-14T06:21:37Z
format Journal Article
id curtin-20.500.11937-8601
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T06:21:37Z
publishDate 2013
publisher American Society of Clinical Oncology
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-86012018-12-14T00:47:30Z Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer Baselga, J. Gomez, P. Greil, R. Braga, S. Climent, M. Wardley, A. Kaufman, B. Stemmer, S. Pego, A. Chan, Arlene Goeminne, J. Graas, M. Kennedy, J. Ciruelos, E.M. Schneeweiss, A. Zubel, A. Groos, J. Melezinkova, H. Awada, A. 2013 Journal Article http://hdl.handle.net/20.500.11937/8601 American Society of Clinical Oncology restricted
spellingShingle Baselga, J.
Gomez, P.
Greil, R.
Braga, S.
Climent, M.
Wardley, A.
Kaufman, B.
Stemmer, S.
Pego, A.
Chan, Arlene
Goeminne, J.
Graas, M.
Kennedy, J.
Ciruelos, E.M.
Schneeweiss, A.
Zubel, A.
Groos, J.
Melezinkova, H.
Awada, A.
Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
title Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
title_full Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
title_fullStr Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
title_full_unstemmed Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
title_short Randomized Phase 11 Study of the Anti-Epidermal Growth Factor Receptor Monoclonal Antibody Cetuximab With Cisplatin Versus Cisplatin Alone in Patients With Metastatis Triple-Negative Breast Cancer
title_sort randomized phase 11 study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatis triple-negative breast cancer
url http://hdl.handle.net/20.500.11937/8601